Fil LTD Has Lowered By $564,376 Its Nasdaq (NDAQ) Holding; Varian Medical Systems Has 0.8 Sentiment

May 23, 2018 - By Louis Casey

Nasdaq, Inc. (NASDAQ:NDAQ) Logo

Varian Medical Systems Inc (VAR) investors sentiment decreased to 0.8 in Q4 2017. It’s down -0.22, from 1.02 in 2017Q3. The ratio dropped, as 185 funds increased and opened new positions, while 231 sold and decreased their positions in Varian Medical Systems Inc. The funds in our database now possess: 87.00 million shares, down from 89.98 million shares in 2017Q3. Also, the number of funds holding Varian Medical Systems Inc in top ten positions was flat from 1 to 1 for the same number . Sold All: 37 Reduced: 194 Increased: 122 New Position: 63.

Fil Ltd decreased Nasdaq Inc (NDAQ) stake by 2.69% reported in 2017Q4 SEC filing. Fil Ltd sold 7,426 shares as Nasdaq Inc (NDAQ)’s stock rose 7.66%. The Fil Ltd holds 269,047 shares with $20.67M value, down from 276,473 last quarter. Nasdaq Inc now has $15.32 billion valuation. The stock increased 0.28% or $0.26 during the last trading session, reaching $91.77. About 429,696 shares traded. Nasdaq, Inc. (NASDAQ:NDAQ) has risen 18.71% since May 23, 2017 and is uptrending. It has outperformed by 7.16% the S&P500.

Ratings analysis reveals 50% of Varian Medical’s analysts are positive. Out of 2 Wall Street analysts rating Varian Medical, 1 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. The lowest target is $93.0 while the high is $98.0. The stock’s average target of $95.50 is -19.59% below today’s ($118.76) share price. VAR was included in 2 notes of analysts from January 23, 2017. The rating was maintained by Barrington Research on Friday, January 27 with “Outperform”. The stock has “Sector Perform” rating by RBC Capital Markets on Monday, January 23.

The stock decreased 0.04% or $0.04 during the last trading session, reaching $118.76. About 346,255 shares traded. Varian Medical Systems, Inc. (VAR) has risen 32.94% since May 23, 2017 and is uptrending. It has outperformed by 21.39% the S&P500.

Since January 1, 0001, it had 0 buys, and 22 insider sales for $22.58 million activity.

Lafleur & Godfrey Llc holds 3.44% of its portfolio in Varian Medical Systems, Inc. for 125,849 shares. Saratoga Research & Investment Management owns 420,832 shares or 3.27% of their US portfolio. Moreover, Capital Counsel Llc Ny has 2.95% invested in the company for 322,779 shares. The Illinois-based Fairpointe Capital Llc has invested 2.51% in the stock. Oakbrook Investments Llc, a Illinois-based fund reported 323,648 shares.

More important recent Varian Medical Systems, Inc. (NYSE:VAR) news were published by: Seekingalpha.com which released: “Varian Medical Systems (VAR) Q2 2018 Results – Earnings Call Transcript” on April 26, 2018, also Twst.com published article titled: “Varian Medical Systems Inc.: Varian Notifies Sirtex It Will Not Submit a Counterproposal to Competing Bid”, Globenewswire.com published: “Recent Analysis Shows Liberty Broadband, Primerica, Adtalem Global Education, Newpark Resources, Varian Medical …” on May 15, 2018. More interesting news about Varian Medical Systems, Inc. (NYSE:VAR) was released by: Businesswire.com and their article: “Glancy Prongay & Murray LLP Continues Investigation on Behalf of Varian Medical Systems, Inc. (VAR) Investors” with publication date: May 15, 2018.

Varian Medical Systems, Inc. designs, makes, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. The company has market cap of $10.87 billion. It operates through two divisions, Oncology Systems and Imaging Components. It has a 89.23 P/E ratio. The Oncology Systems segment provides hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy.

Analysts await Varian Medical Systems, Inc. (NYSE:VAR) to report earnings on July, 25. They expect $1.00 earnings per share, down 3.85% or $0.04 from last year’s $1.04 per share. VAR’s profit will be $91.51M for 29.69 P/E if the $1.00 EPS becomes a reality. After $1.15 actual earnings per share reported by Varian Medical Systems, Inc. for the previous quarter, Wall Street now forecasts -13.04% negative EPS growth.

Investors sentiment increased to 1.22 in Q4 2017. Its up 0.07, from 1.15 in 2017Q3. It improved, as 25 investors sold NDAQ shares while 137 reduced holdings. 56 funds opened positions while 141 raised stakes. 119.93 million shares or 0.85% less from 120.96 million shares in 2017Q3 were reported. Amp Capital Ltd accumulated 0.03% or 76,905 shares. Pitcairn owns 0.09% invested in Nasdaq, Inc. (NASDAQ:NDAQ) for 11,811 shares. Mason Street Advisors Ltd has 16,208 shares for 0.03% of their portfolio. Ing Groep Nv has invested 0.01% in Nasdaq, Inc. (NASDAQ:NDAQ). Quantitative Inv Management Ltd Liability Com owns 81,600 shares. Cwm Lc holds 82 shares. Aperio Ltd Co holds 0.06% or 140,645 shares in its portfolio. Oregon-based Peregrine Asset Advisers has invested 0.19% in Nasdaq, Inc. (NASDAQ:NDAQ). Reilly Advsr Ltd invested in 0% or 304 shares. Jefferies Grp Ltd Company has invested 0.02% of its portfolio in Nasdaq, Inc. (NASDAQ:NDAQ). State Of New Jersey Common Pension Fund D has invested 0.01% in Nasdaq, Inc. (NASDAQ:NDAQ). Kentucky Retirement holds 0.04% of its portfolio in Nasdaq, Inc. (NASDAQ:NDAQ) for 7,175 shares. Nordea accumulated 142,545 shares. Ahl Limited Liability Partnership has 149,161 shares. Fjarde Ap owns 0.04% invested in Nasdaq, Inc. (NASDAQ:NDAQ) for 37,142 shares.

Analysts await Nasdaq, Inc. (NASDAQ:NDAQ) to report earnings on July, 25. They expect $1.18 earnings per share, up 15.69% or $0.16 from last year’s $1.02 per share. NDAQ’s profit will be $197.01 million for 19.44 P/E if the $1.18 EPS becomes a reality. After $1.24 actual earnings per share reported by Nasdaq, Inc. for the previous quarter, Wall Street now forecasts -4.84% negative EPS growth.

Since January 12, 2018, it had 0 buys, and 8 insider sales for $6.54 million activity. Griggs PC Nelson sold $178,840 worth of stock or 2,000 shares. Peterson Bradley J sold $1.55M worth of stock. KNIGHT EDWARD S had sold 26,258 shares worth $2.32 million on Friday, April 27. Ottersgard Lars also sold $520,918 worth of Nasdaq, Inc. (NASDAQ:NDAQ) shares. $326,863 worth of Nasdaq, Inc. (NASDAQ:NDAQ) was sold by BEGLEY CHARLENE T. Shares for $508,926 were sold by SIBBERN BJORN on Friday, April 27.

Among 19 analysts covering NASDAQ OMX Group (NASDAQ:NDAQ), 10 have Buy rating, 1 Sell and 8 Hold. Therefore 53% are positive. NASDAQ OMX Group had 73 analyst reports since August 9, 2015 according to SRatingsIntel. The firm earned “Outperform” rating on Thursday, March 10 by Credit Suisse. As per Monday, July 17, the company rating was maintained by RBC Capital Markets. The rating was maintained by Keefe Bruyette & Woods with “Hold” on Thursday, June 1. The firm has “Hold” rating by RBC Capital Markets given on Monday, October 16. The rating was maintained by Deutsche Bank on Wednesday, October 5 with “Buy”. Keefe Bruyette & Woods maintained Nasdaq, Inc. (NASDAQ:NDAQ) rating on Wednesday, March 28. Keefe Bruyette & Woods has “Hold” rating and $9000 target. On Wednesday, October 11 the stock rating was maintained by Jefferies with “Hold”. The firm has “Neutral” rating by Goldman Sachs given on Monday, January 11. The firm has “Buy” rating given on Friday, April 6 by Deutsche Bank. The company was maintained on Friday, April 1 by Wood.

Fil Ltd increased Mosaic Co New (NYSE:MOS) stake by 381,220 shares to 10.23M valued at $262.51 million in 2017Q4. It also upped Jacobs Engr Group Inc Del (NYSE:JEC) stake by 15,356 shares and now owns 2.26 million shares. Hollysys Automation Technolo (NASDAQ:HOLI) was raised too.

More notable recent Nasdaq, Inc. (NASDAQ:NDAQ) news were published by: Globenewswire.com which released: “Nasdaq Halts Rockwell Medical, Inc.” on May 23, 2018, also Nasdaq.com with their article: “Nasdaq (NDAQ) 1st Quarter Earnings: What to Expect” published on April 24, 2018, Nasdaq.com published: “Nasdaq Welcomes EVO Payments, Inc. (Nasdaq: EVOP) to The Nasdaq Stock Market” on May 23, 2018. More interesting news about Nasdaq, Inc. (NASDAQ:NDAQ) were released by: Nasdaq.com and their article: “Nasdaq (NDAQ) Beats on Q1 Earnings, Trims Expense Guidance” published on April 25, 2018 as well as Seekingalpha.com‘s news article titled: “Nasdaq (NDAQ) Q1 2018 Results – Earnings Call Transcript” with publication date: April 25, 2018.

Varian Medical Systems, Inc. (NYSE:VAR) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>